These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Enhanced gene expression of renin-angiotensin system, TGF-beta1, endothelin-1 and nitric oxide synthase in right-ventricular hypertrophy. Park HK; Park SJ; Kim CS; Paek YW; Lee JU; Lee WJ Pharmacol Res; 2001 Mar; 43(3):265-73. PubMed ID: 11401419 [TBL] [Abstract][Full Text] [Related]
26. Effect of pentoxifylline on graft function of renal transplant recipients complicated with chronic allograft nephropathy. Shu KH; Wu MJ; Chen CH; Cheng CH; Lian JD; Lu YS Clin Nephrol; 2007 Mar; 67(3):157-63. PubMed ID: 17390740 [TBL] [Abstract][Full Text] [Related]
27. Losartan decreases plasma levels of TGF-beta1 in transplant patients with chronic allograft nephropathy. Campistol JM; Iñigo P; Jimenez W; Lario S; Clesca PH; Oppenheimer F; Rivera F Kidney Int; 1999 Aug; 56(2):714-9. PubMed ID: 10432413 [TBL] [Abstract][Full Text] [Related]
29. Direct renin inhibition in a rat model of chronic allograft injury. Rusai K; Schmaderer C; Hermans JJ; Lutz J; Heemann U; Baumann M Transplantation; 2011 Nov; 92(9):999-1004. PubMed ID: 21956196 [TBL] [Abstract][Full Text] [Related]
30. No association between renin-angiotensin system gene polymorphisms and early and long-term allograft dysfunction in kidney transplant recipients. Slowinski T; Diehr P; Kleemann P; Fritsche L; Renders L; Budde K; Hauser IA; Neumayer HH; Hocher B Nephrol Dial Transplant; 2004 Nov; 19(11):2846-51. PubMed ID: 15353577 [TBL] [Abstract][Full Text] [Related]
31. Intragraft messenger RNA expression of angiotensinogen: relationship with transforming growth factor beta-1 and chronic allograft nephropathy in kidney transplant patients. Mas V; Alvarellos T; Giraudo C; Massari P; De Boccardo G Transplantation; 2002 Sep; 74(5):718-21. PubMed ID: 12352892 [TBL] [Abstract][Full Text] [Related]
32. Canine ventricular myocytes possess a renin-angiotensin system that is upregulated with heart failure. Barlucchi L; Leri A; Dostal DE; Fiordaliso F; Tada H; Hintze TH; Kajstura J; Nadal-Ginard B; Anversa P Circ Res; 2001 Feb; 88(3):298-304. PubMed ID: 11179197 [TBL] [Abstract][Full Text] [Related]
33. Role of proteinuria in the regulation of renal renin-angiotensin system components in unilateral proteinuric rats. Deelman LE; Navis G; de Boer E; Wietses M; de Zeeuw D; Henning RH J Renin Angiotensin Aldosterone Syst; 2003 Mar; 4(1):38-42. PubMed ID: 12692752 [TBL] [Abstract][Full Text] [Related]
35. Altered genes profile of renin-angiotensin system, immune system, and adipokines receptors in leukocytes of children with primary hypertension. Litwin M; Michałkiewicz J; Trojanek J; Niemirska A; Wierzbicka A; Szalecki M Hypertension; 2013 Feb; 61(2):431-6. PubMed ID: 23266543 [TBL] [Abstract][Full Text] [Related]
36. [Renal gene expression of renin and transforming growth factor Beta 1 in children with glomerulonephritis]. Ciechanowicz A; Brodkiewicz A; Adler G; Kurzawska O; Juszkiewicz P; Krygier-Stojałowska A; Fydryk J Pol Merkur Lekarski; 2001 Apr; 10(58):250-5. PubMed ID: 11434169 [TBL] [Abstract][Full Text] [Related]
37. Renal dysfunction and intragraft proMMP9 activity in renal transplant recipients with interstitial fibrosis and tubular atrophy. Racca MA; Novoa PA; Rodríguez I; Della Vedova AB; Pellizas CG; Demarchi M; Donadio AC Transpl Int; 2015 Jan; 28(1):71-8. PubMed ID: 25179305 [TBL] [Abstract][Full Text] [Related]
38. The role of nitric oxide and the renin-angiotensin system in salt-restricted Dahl rats. Kataoka H; Otsuka F; Ogura T; Yamauchi T; Kishida M; Takahashi M; Mimura Y; Makino H Am J Hypertens; 2001 Mar; 14(3):276-85. PubMed ID: 11281241 [TBL] [Abstract][Full Text] [Related]
39. Recipient RAS gene variants and renal allograft function. Nicod J; Richard A; Frey FJ; Ferrari P Transplantation; 2002 Mar; 73(6):960-5. PubMed ID: 11923700 [TBL] [Abstract][Full Text] [Related]
40. Local neurohumoral regulation in the transition to isolated diastolic heart failure in hypertensive heart disease: absence of AT1 receptor downregulation and 'overdrive' of the endothelin system. Yamamoto K; Masuyama T; Sakata Y; Doi R; Ono K; Mano T; Kondo H; Kuzuya T; Miwa T; Hori M Cardiovasc Res; 2000 Jun; 46(3):421-32. PubMed ID: 10912453 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]